InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Atlas Venture Fund X, LP. Officer active across 1 company, notably Kymera Therapeutics, Inc.. In total, 8 reports have been recorded. Activity tracked since 17 June 2026. The latest transaction was disclosed on 29 June 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations